Trevi Therapeutics Inc (TRVI)
2.59
+0.05
(+1.97%)
USD |
NASDAQ |
Apr 26, 11:36
Trevi Therapeutics Total Liabilities (Quarterly): 6.856M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.856M |
| September 30, 2023 | 6.286M |
| June 30, 2023 | 5.904M |
| March 31, 2023 | 14.47M |
| December 31, 2022 | 15.56M |
| September 30, 2022 | 18.46M |
| June 30, 2022 | 20.90M |
| March 31, 2022 | 19.92M |
| December 31, 2021 | 21.40M |
| September 30, 2021 | 20.22M |
| June 30, 2021 | 21.41M |
| Date | Value |
|---|---|
| March 31, 2021 | 19.18M |
| December 31, 2020 | 19.85M |
| September 30, 2020 | 20.26M |
| June 30, 2020 | 6.972M |
| March 31, 2020 | 7.436M |
| December 31, 2019 | 5.456M |
| September 30, 2019 | 5.313M |
| June 30, 2019 | 7.413M |
| March 31, 2019 | 4.51M |
| December 31, 2018 | 4.278M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.313M
Minimum
Sep 2019
21.41M
Maximum
Jun 2021
13.86M
Average
15.56M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Accuray Inc | 428.70M |
| Vanda Pharmaceuticals Inc | 103.53M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.40M |
| Shareholders Equity (Quarterly) | 82.55M |